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VAPOCOOLANT SPRAY’S EFFECT ON PIVC PAIN  
Abstract 
Intravenous (IV) cannulation is required to administer medications and fluids to patients. 
In addition, it is also a recognized source of pain and anxiety in over one-half of all patients 
requiring IV insertion (Page & Taylor, 2010). Pain management is within nurses’ scope of 
practice, therefore it’s important to identify effective pain management strategies. The purpose of 
this study is to determine the effect that a topical vapocoolant spray has on pain in pre-operative 
adults during IV cannulation. The gate control theory of pain will guide this randomized, 
experimental study of a convenience sample of adults in an outpatient endoscopic floor at a 
Northeast Ohio level one-trauma center. Participants are randomly assigned to groups based on 
even weeks of the month (control group) and odd weeks (experimental group). Participants will 
rate pain at pre- and post- procedures on visual analog scales. Independent two sample t-tests 
will be used to determine group differences. In relation to our research investigation, we 
analyzed both groups’ answers to one question: “How painful was the needle stick?” on a scale 
of 1-10, 10 being most painful. The reported pain score of the non-spray group was 3.33, 
compared to the spray group mean of 2.86. These averages are rather close in value, suggesting 
no significant difference in perceived pain level with the use of the vapocoolant spray prior to IV 
insertion. 
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Introduction 
As nurses, the ability to start intravenous (IV) infusion lines with minimal pain and 
discomfort in patients is important since our scope of practice includes effective pain 
management. This is especially important for the pre-operative population when IV lines serve 
the purpose of injecting medication for anesthesia during surgery and administering necessary 
fluid therapy. They may also be used to provide medication to treat pain and nausea. IV-related 
insertion pain can be a consequence that can adversely affect patient experience and the patient-
nurse relationship. Patients frequently report pain as a side effect of IV cannulation, which may 
increase anxiety in hospitalized patients (Jacobsen, 2006). Preoperational anxiety is a concern 
that occurs in more than half of all patients that go into surgery (Nigussie, Belachew, & 
Wolancho, 2014). Decreasing patient’s pain from IV cannulation could increase patient 
satisfaction while decreasing the negative physiologic pain effects, which include disruption of 
the body’s normal functioning, activation of the sympathetic nervous system, release of various 
hormones, and disruption to homeostasis (Sessle, 2011). So, it becomes important not to increase 
or add to pre-operative anxiety or pain with IV cannulation. In the United States, over 100 
million surgical procedures are performed annually (Winfield et al., 2013). Since IV insertion is 
performed for nearly all surgical procedures, there is a need to make the process painless. 
Researchers have examined the effects of intradermal anesthetics, such as the application 
of lidocaine, on pain and anxiety in pre-operative patients. Brown (2003) compared the 
application of lidocaine prior to IV insertion and found that IV cannulations were less painful 
with the use of lidocaine. However, few have investigated the effect of cold, topical sprays on IV 
pain. The following research question will be answered: In adult pre-operative patients during IV 
cannulations, how does the application of a vapocoolant, topical spray affect pain score? Our 
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group will be working under Dr. Brian Radesic and Angelo Donatelli, a Doctor of Nursing 
Practice (DNP) student, to study the effect of the application of a vapocoolant, topical spray on 
IV pain score during the pre-operative period. Data will be collected over the timeline of three 
months and include subjects with a variety of cultural, ethnic, and lifestyle backgrounds. 
Review of Literature 
Researchers have examined pain of IV cannulations in children (Waterhouse, Liu, & 
Wang, 2013), hemo-dialysis patients (Celik, Ozbek, Yilmaz, Duman, & Apiliogullari, 2011), and 
adult patients in various settings including; emergency department patients (Hijazi, Taylor, & 
Richardson, 2008), patients in an international travel clinic (Mawhorter, Daugherty, Ford, 
Hughes, Metzger, & Easley, 2001), outpatient procedures (Deguzman, O’Mara, Sulo, Haines, 
Blackburn, & Corazza, 2012), and inpatient procedures (Brown, 2003). All have found that IV 
cannulations cause stress, anxiety, and pain, regardless of patient demographics. Researchers 
have also studied the effects of different interventions on pain in patients during IV cannulation. 
These interventions include the use of ice on the skin (Waterhouse et al., 2013), lidocaine 
injection prior to IV cannulation (Brown, 2003), Eutectic Mixture of Local Anesthetics (EMLA) 
cream composed of 2.5% lidocaine and 2.5% prilocaine (Mawhorter et al., 2001), topical 
lidocaine (ELA-MAX) cream composed of 5% lidocaine (Luhmann, Hurt, Shootman, & 
Kennedy, 2004), and a topical vapocoolant spray (Celik et al., 2011). Although ice application, 
compared to no ice, during IV cannulation decreased pain score in 47% of patients, when 
compared with a topical vapocoolant spray, ice was shown to be less effective (Waterhouse et 
al., 2013). In general, researchers have found that lidocaine injection prior to IV cannulation, 
application of EMLA cream, application of ELA-MAX cream, and a topical vapocoolant spray 
each decrease pain and anxiety during IV cannulations. In addition, they found the application of 
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a topical vapocoolant spray to be the most effective when considering cost and time management 
(Page, & Taylor, 2010). 
Several interventions have limitations, for example, lidocaine injections lowered IV 
insertion pain, but at the same time may have contributed to pain and anxiety, because the 
lidocaine was also injected (Beck, Zbierajewski, Barber, Engoren, & Thomas, 2011) and 
possibly an additional reason for pain and anxiety. Topical EMLA and ELA-MAX creams 
decreased IV insertion pain and anxiety by numbing the skin and are not invasive, but they may 
take 30-45 minutes to have effect on IV cannulation pain (Kleiber, Sorenson, Whiteside, 
Gronstal, & Tannous, 2002) which is precious time in the pre-op surgical areas. It is also 
important to note that lidocaine and prilocaine can be contraindicated for patients with heart 
problems. The vapocoolant sprays were determined to be just as effective as the local anesthetics 
(Hijazi et al., 2008), as well as more cost-effective and instantaneous because its action takes a 
matter of seconds to numb the area (Hijazi et al., 2008).  This research study aims to determine 
the effect of topical vapocoolant sprays on pain score in adult patients on an outpatient 
endoscopy floor. 
Theoretical Framework 
           The gate control theory of pain proposes that a nonpainful stimuli (i.e., massage, heat, ice) 
interrupts the transduction of signal from a painful stimulus (Deardorff, 2016). The spinal cord is 
the center for pain signal transduction. When a painful stimulus is encountered, a signal is sent 
from the affected nerve to the spinal cord, which transmits the signal to the brain so the body 
responds appropriately. In the gate control theory of pain, “the sensitivity of the nociceptive 
system can be decreased or increased and this ‘gate control’ can occur at peripheral, spinal, and 
supraspinal levels. The resulting changes in pain sensitivity can be rapidly reversible or 
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persistent, highly localized or widespread” (Treede, 2016). Decreased sensitization to the 
reception of pain signals in the brain may then reduce the pain that a person experiences. The 
gate control theory of pain suggests that the introduction of a nonpainful stimuli may interrupt 
the transmission of a painful signal to the brain. The gate control theory of pain states that, 
“nociceptive (pain arising from nerve cells) and non-nociceptive signals are summated within the 
substantia gelatinosa (spinal cord). If nociceptive signals outweigh non-nociceptive signals, a 
pain signal is propagated” (Kirkpatrick et al., 2015).  For example, if an individual were to hit 
their arm on a door, natural responses would be to rub the affected area. The rubbing of the 
affected area introduces a cutaneous stimulation that interferes with the amount of pain the 
person is experiencing. Rather than only interpreting the pain from the affected area, the nervous 
system will now also interpret the cutaneous stimulation that is being received from the rubbing. 
Since there are a limited number of pathways that stimuli can be transmitted through, introducing 
a nonpainful stimulus forces some of the pathways to interpret the nonpainful stimulus, rather 
than interpreting the painful stimulus. The introduction of this nonpainful stimulus decreases the 
amount of pain the individual is experiencing by forcing the body to interpret a secondary 
stimulus instead of the pain. If the individual were to stop rubbing their arm, suddenly they may 
feel more pain due to the fact that there are more gates, or nerve pathways, open to interpret the 
pain faster. The rubbing may strategically close these gates. Since the sprays work by numbing 
the local area and use the cold as a distraction, the study is guided by the gate control theory of 
pain.   
IV cannulation creates a superficial-sharp pain as a result of direct trauma to the skin due 
to nociception; the body’s response to painful stimulus. The purpose of this study is to examine 
the effect of a vapocoolant spray on pain score during IV cannulation. The brain modulates pain 
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signals by controlling endorphins which stop the transmission of substance P, a “peptide 
neurotransmitter which modulates sensitivity to pain” (Felipe, Herrero, Obrien, Palmer, Doyle, 
Smith, & Hunt, 1998). This is applicable to our study because the same principle is being used 
with the vapocoolant spray. The cooling effects and stimulation of the spray activate the gate 
control theory and slow the reception of painful stimuli. Based on this theory, it is anticipated the 
application of a vapocoolant spray prior to IV cannulation will decrease the pain score 
experienced by the participant during IV cannulation.  
Methods 
Design 
           This experimental investigation is testing the effect of a 95% Pentafluoropropane/5% 
Tetrafluoroethrane topical vapocoolant spray on pain score in pre-operative patients during IV 
cannulation. Study protocol has been approved by the hospital Institutional Review Board (IRB). 
This secondary analysis study proposal was submitted and approved by the University of Akron 
IRB. Gabauer Company provided the vapocoolant spray. The company provided no other 
support, nor did it influence the design, conduct or reporting of the study. 
Site and Population 
           The site of this experiment is an outpatient endoscopic floor in a Northeast Ohio level 
one-trauma center located at a 532-bed, urban, teaching hospital. Inclusion criteria include: 
ability to speak, write, and read English, between the ages of 18 to 85, and scheduled for an 
outpatient endoscopic procedure between December 2016 and April 2017. Exclusion criteria 
includes: Raynaud’s, PVD, allergy to aerosol, cold intolerance, frostbite history, frail/thin skin, 
diabetes mellitus, renal dialysis, pregnant, in-patient population, patient refusal, and product 
allergy.  
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Sampling Procedures and Recruitment 
          The consenting process will consist of written and verbal explanations (see appendix A). 
Subjects will sign a privacy release, giving access to medical records for data collection. 
Informed consent will be documented by receiving the subject’s initials on each sheet of the 
consent form and signature at the end of the consent form. During the even weeks of the months, 
the subjects who consent will be assigned to the control group and receive standard care. During 
the odd weeks of the months subjects who consent will be assigned to the experimental group. 
Data Collection 
           After obtaining informed consent, research team members will collect all demographic 
data, medical history, and comorbidities from pre-screening assessments in patient charts, to 
determine eligibility. All data collected during the pre-screening for eligibility will be destroyed 
via the shredding cabinet if subjects are ineligible to participate in the study. For the study, a 
total of 128 patients is needed to achieve the effect size of 0.5 for this study, or 64 patients in 
each study group.  
           Subjects complete pre- and post- questionnaires (see Appendix B) that will measure a 
baseline of previous PIVC experience and pain during IV cannulations. The questionnaire has 
multiple questions and uses a zero to ten pain scale; zero being no pain and ten being the most 
severe pain. Data collection will be obtained by a research team member.  
Measures 
           Pain is measured with a visual analogue scale (VAS). It has established validity and 
reliability in a study to measure sensory intensity and affective magnitude of both chronic and 
experimental pain (Price, Mcgrath, Rafii, & Buckingham, 1983). The scale asks participants to 
rate their pain on a scale from zero to ten, zero being no pain at all and ten being severe pain.  
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Data Analysis 
           Data was analyzed based on level of variable measure with nominal level data analyzed 
with descriptive statistics to describe the sample and pain variable. Summed ordinal, interval, 
and ratio level data will be analyzed with inferential statistics. An independent sample t-test will 
determine group differences on demographics prior to the intervention, which will describe 
group differences and similarities. After the intervention, an independent sample t-test will 
determine group differences of pain score with statistical significance set at <.05 
Time Line for Completion 
This honors nursing research project is working with a University of Akron DNP student 
Angelo G. Donatelli, and is sponsored by Dr. Radesic, Brian DNP, MSN, CRNA, who is the 
Director of The University of Akron’s Nurse Anesthesia Program, and Assistant Director of 
School of Nursing. Our proposal to the Honors College and UA IRB was approved at the 
beginning of the spring semester in January 2017. We chose to enroll in the senior honors project 
independent study in Fall 2017, and/or Spring 2018. Data collection for this project occurred 
between December 2016 and April 2017 and was subject to further instruction from the lead 
researcher, Angelo G. Donatelli. After we collected data on the first 128 patients, we were 
granted access to the data for analysis. During this time period we analyzed the necessary data 
for our honors project and record the findings. 
Results 
One hundred twenty-eight patients were randomly divided into either the control group, or 
experimental spray group. Placement in either group was determined by the week of the month. 
Sixty-four eligible patients that were consented during an even week of the month were placed in 
the control group. Sixty-four eligible patients that were consented during an odd week of the month 
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were placed in the experimental group. It is worth noting that the two groups differed in age, 
gender, IV cannulation site, cannula size, and staff member inserting cannula. Reported pain for 
most patients in both groups was low (Table two) and did not significantly differ between the 
two groups (P=0.179, and t= - 1.35). The mean reported pain level for patients in the control 
group was 3.33, while the mean reported pain level for the experimental group was 2.86 (Table 
one). After reviewing the collected data, no significant pain reduction could be proven in patients 
receiving the vapocoolant spray prior to IV cannulation, as opposed to patients receiving no 
treatment. 
Discussion 
 The results of the patients' surveys following IV insertion showed that the control group 
and experimental group did not differ significantly in a difference of pain. The pain for both 
groups were reported on a visual analogue scale of one to ten (1-10). The experimental group 
had an average reported pain of 2.86, while the control group had an average reported pain of 
3.33. The significant differing between these two results is rather very little. Therefore, from this 
study it is hard to assess if there is any clinical evidence to suggest that the vapocoolant spray 
provides any therapeutic comfort for the patients. 
 This finding was an unexpected finding due to the information synthesized from the 
literature review, in which there was overwhelming evidence that any intervention was better 
than no intervention at all. In a study with over 1,000 patients on the application of ice as a prior 
intervention, it showed that 47% of the sample showed a significant relief of pain from that 
intervention (Waterhouse et al., 2013). Following up with that, the same study indicated that a 
topical vapocoolant spray was more effective than ice (Waterhouse et al., 2013). With those 
conclusions alone, it was safely assumed that the vapocoolant spray in this study would produce 
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differing results from the control group. However, with only 47% of the sample indicating that a 
less effective intervention was better than no intervention at all, it is likely that this current study 
under review has too small of a sample size.  
 The theoretical framework that coincides with this study was the gate control theory, 
which is that one non-painful stimulus may interrupt the pain transmission of a painful stimulus. 
In theory this is very sound. Although common subjective data seen with patients receiving the 
vapocoolant spray were that there was slight discomfort in how cold the intervention was. This 
may indicate that although a cold stimulus is considered a non-painful stimulus in this study, it 
may still be a discomforting stimulus. In other words, this study may be trading one 
discomforting stimuli for another. Therefore, further testing should be conducted that has a 
controlled and narrower patient population, a larger sample size, and fewer nurses conducting IV 
insertions. It would be highly beneficial if it could just be a single nurse that conducts future IV 
insertions with this type of study. 
Conclusion 
Our secondary analysis involved 128 total subjects, 64 in the control group and 64 in the 
experimental group. The experimental group received an application of the vapocoolant spray 
prior to IV cannulation, while the control group underwent standard treatment and did not 
receive the vapocoolant spray. Upon conclusion of the IV insertion all subjects were asked to 
complete a brief questionnaire about their IV experience. In relation to our research 
investigation, we analyzed both groups’ answers to one question: “How painful was the needle 
stick?” on a scale of 1-10, 10 being most painful. The reported pain score of the non-spray group 
was 3.33, compared to the spray group mean of 2.86. These averages are rather close in value, 
suggesting no significant difference in perceived pain level with the use of the vapocoolant spray 
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prior to IV insertion. One limitation to this secondary analysis was the low sample size. A larger 
sample size would decrease the risk of variability and provide an accurate analysis. Additionally, 
data collection was limited to nurse availability.  
In regards to the implications for the future of nursing practice, additional studies need to 
be collected with vapocoolant sprays, or a similar topical, cold spray. Subject-reported pain 
levels are inconclusive, and do not support the hypothesis that the application of a topical cold 
spray prior to IV cannulation decreases pain score during the procedure. Future studies could 
research separate potential effects of the application of a cold spray prior to IV insertion, aside 
from pain. This would include patient anxiety, as well as the nurse’s confidence.  
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Table Two 
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Appendix A 
Title: Exploring Patient Satisfaction and Nurse’s Peripheral Intravenous Catheter (PIVC) Insertion Using a 
Vapocoolant 
 
Principle Investigator: Angelo G. Donatelli MSN, CRNA 
Other Investigators: Julie Imani MSN, CNS, OCN, Brian Radesic DNP, MSN, CRNA, Richard Kucera MSN, 
CRNA 
Institutional affiliations: The University of Akron and Cleveland Clinic Akron General 
 
 
 
Doctors and nurses want to know more about how our care affects patients.  One way to learn this is by 
asking patients to take part in research studies.  Angelo G. Donatelli MSN, CRNA, is leading this study. 
 
You are being invited join in this research study because you are going to have an IV started today. 
Before you agree to take part, you need to know what this study is about.  The purpose of this study is 
to understand how starting an IV affects the patient.  In this study we want to know if using a cold spray 
before the needle stick makes a difference.  Some study patients will receive the standard IV start used 
in the endoscopy unit.  Other study patients will receive a cold spray before the IV start.  The study 
patients will be placed into one of these two groups.  You will be asked to answer questions about your 
IV experiences.  The questions will have answers for you to circle your responses. One goal of this study 
is to improve patient satisfaction with the IV start.  This study will want to know if the cold spray helps 
the nurse start the IV. 
 
Joining this study is voluntary. If you do not wish to join in the study, you will still receive the standard 
therapy used by your physician in the treatment of your disease or condition. 
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Appendix B 
Patient IV Experience Questionnaire 
 
 
Pre-IV start questions 
1. Have you ever had an IV before? Yes No     I don’t know 
 
If you answered yes, please continue. Otherwise you are finished with this questionnaire. 
 
2. Think about your most recent IV start.  Please rate your satisfaction with the needle stick? 
 
 
                    1                2                3               4               5               6               7              8             9              10 
Very Satisfied           Very Dissatisfied  
3. Circle how many needle sticks it took to place your most recent IV. 
 
1  2  3  more than 3   I don’t recall 
 
4. With your most recent needle stick, please circle which one of the following was used to lessen the pain 
from the needle stick:  
 
Cold spray     Numbing Cream    Can’t recall        Other____________ 
 
5. If a product was used to lessen the pain, rate how satisfied you were with this product (or with the result)? 
 
 
                    1                2                3               4               5               6               7              8             9              10 
Very Satisfied           Very Dissatisfied   
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Post IV start questions: No spray group 
1. Was there anything that could have made the IV start today better? (Choose all that apply) 
• Something was used to decrease the pain of the needle 
• Nothing because it was ok 
• Nothing because it always hurts 
• Other______________________________________________________________ 
 
2. How painful was the needle stick? 
 
 
 
     1                 2                3                 4                  5               6                7              8               9                10 
No Pain           Worst Pain 
3. How did the pain from the needle stick affect your satisfaction with your IV experience? 
 
 
    1                2                3                   4                   5                 6                  7              8                 9       10 
No Affect           Major Affect  
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Post IV start questions: Spray group 
1. Did the cold spray lessen the pain for the needle stick today? 
 
 
      1                2                3               4                  5               6               7              8             9             10 
No Affect           Major Affect 
2. How painful was the needle stick? 
 
 
     1                 2                3                 4                  5               6                7              8               9                10 
  No Pain          Worst Pain 
 
3. How did the pain from the needle stick affect your satisfaction with your IV experience? 
 
     1                2                3               4                   5               6               7              8             9             10 
No Affect           Major Affect 
 
 
